135 related articles for article (PubMed ID: 37163357)
1. FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years.
Shimony S; Fell G; Chen EC; Tsai HK; Wadleigh M; Winer ES; Garcia JS; Luskin MR; Stahl M; Neuberg DS; DeAngelo DJ; Lindsley RC; Stone RM
Blood Adv; 2023 Sep; 7(18):5354-5358. PubMed ID: 37163357
[TBL] [Abstract][Full Text] [Related]
2. FLT3 and FLT3-ITD gene mutations and prognosis in patients with acute myeloid leukemia.
Chen LG; Pei RZ; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Cao JJ; Li SY
J Biol Regul Homeost Agents; 2019; 33(6):1855-1861. PubMed ID: 31718764
[No Abstract] [Full Text] [Related]
3. A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.
Ostronoff F; Othus M; Kantarjian HM; Meshinchi S; Ravandi F; Hendrie PC; Faderl S; Becker PS; Cortes JE; Pagel JM; Petersdorf SH; Godwin JE; Willman CL; Pierce SA; List AF; Sandhu RK; Walter RB; Stirewalt DL; Appelbaum FR; Estey EH
Br J Haematol; 2013 Oct; 163(1):130-2. PubMed ID: 23829510
[No Abstract] [Full Text] [Related]
4. Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia.
Nazha A; Cortes J; Faderl S; Pierce S; Daver N; Kadia T; Borthakur G; Luthra R; Kantarjian H; Ravandi F
Haematologica; 2012 Aug; 97(8):1242-5. PubMed ID: 22532519
[TBL] [Abstract][Full Text] [Related]
5. Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study.
Nasilowska-Adamska B; Czyz A; Markiewicz M; Rzepecki P; Piatkowska-Jakubas B; Paluszewska M; Dzierzak-Mietla M; Solarska I; Borg K; Prochorec-Sobieszek M; Szydlo R; Lewandowski K; Skotnicki A; Jedrzejczak WW; Kyrcz-Krzemien S; Komarnicki M; Warzocha K
Eur J Haematol; 2016 Mar; 96(3):236-44. PubMed ID: 25912052
[TBL] [Abstract][Full Text] [Related]
6. [Detection and clinical significance of FLT3-ITD gene mutation in patients with acute myeloid leukemia].
Xu YY; Gao L; Ding Y; Sun JZ; Wang N; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1312-5. PubMed ID: 23257423
[TBL] [Abstract][Full Text] [Related]
7. Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.
Koszarska M; Meggyesi N; Bors A; Batai A; Csacsovszki O; Lehoczky E; Adam E; Kozma A; Lovas N; Sipos A; Krahling T; Dolgos J; Remenyi P; Fekete S; Masszi T; Tordai A; Andrikovics H
Leuk Lymphoma; 2014 Jul; 55(7):1510-7. PubMed ID: 24090502
[TBL] [Abstract][Full Text] [Related]
8. The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan.
Lyu M; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Gene; 2020 Feb; 726():144195. PubMed ID: 31669649
[TBL] [Abstract][Full Text] [Related]
9. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A
Am J Hematol; 2018 Jun; 93(6):736-744. PubMed ID: 29498106
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD.
de Jonge HJ; Valk PJ; de Bont ES; Schuringa JJ; Ossenkoppele G; Vellenga E; Huls G
Haematologica; 2011 Sep; 96(9):1310-7. PubMed ID: 21606167
[TBL] [Abstract][Full Text] [Related]
11. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
[TBL] [Abstract][Full Text] [Related]
12. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients.
El Gammal MM; Ebid GT; Madney YM; Abo-Elazm OM; Kelany AK; Torra OS; Radich JP
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e281-e290. PubMed ID: 30926392
[TBL] [Abstract][Full Text] [Related]
13. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].
Han YL; Zhang SJ; Qiao C; Dai D; Sun XM; Xu YL; Qian SX; Xu W; Wang JS; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1135-9. PubMed ID: 19840437
[TBL] [Abstract][Full Text] [Related]
14. FLT3-ITD and CEBPA Mutations Predict Prognosis in Acute Myelogenous Leukemia Irrespective of Hematopoietic Stem Cell Transplantation.
Wang H; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
Biol Blood Marrow Transplant; 2019 May; 25(5):941-948. PubMed ID: 30503388
[TBL] [Abstract][Full Text] [Related]
15. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197
[TBL] [Abstract][Full Text] [Related]
16. Positive Minimal Residual Disease of FLT3-ITD before Hematopoietic Stem Cell Transplantation Resulted in a Poor Prognosis of an Acute Myeloid Leukemia.
Iwasaki Y; Nishiuchi R; Aoe M; Takahashi T; Watanabe H; Tokorotani C; Kikkawa K; Shimada A
Acta Med Okayama; 2017 Feb; 71(1):79-83. PubMed ID: 28238014
[TBL] [Abstract][Full Text] [Related]
17. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in
Sharawat SK; Raina V; Kumar L; Sharma A; Bakhshi R; Vishnubhatla S; Gupta R; Bakhshi S
Indian J Med Res; 2016 May; 143(Supplement):S11-S16. PubMed ID: 27748272
[TBL] [Abstract][Full Text] [Related]
18. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutations.
Hirsch P; Qassa G; Marzac C; Tang R; Perrot JY; Isnard F; Mohty M; Marie JP; Legrand O
Leuk Lymphoma; 2015 Jan; 56(1):147-50. PubMed ID: 24724782
[TBL] [Abstract][Full Text] [Related]
20. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
